The establishment of a homozygous SNTA1 knockout human embryonic stem cell line (WAe009-A-50) using the CRISPR/Cas9 system

被引:2
|
作者
Dong, Tao [1 ,2 ]
Zhang, Siyao [1 ,2 ]
Chang, Yun [1 ,2 ]
Bai, Rui [1 ,2 ]
Jiang, Youxu [1 ,2 ]
Ma, Shuhong [1 ,2 ]
Li, Yanan [1 ,2 ]
Jiang, Hong Feng [1 ,2 ]
Lu, Wen-Jing [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Collaborat Innovat Ctr Cardiovasc Disorde, Beijing Lab Cardiovasc Precis Med,Minist Educ, Anzhen Hosp,Key Lab Remodeling Related Cardiovasc, Beijing 100029, Peoples R China
[2] Beijing Inst Heart, Lung & Blood Vessel Dis, Beijing 100029, Peoples R China
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
D O I
10.1016/j.scr.2021.102196
中图分类号
Q813 [细胞工程];
学科分类号
摘要
SNTA1 encodes alpha 1-syntrophin, a scaffold protein, which is a component of the dystrophin-associated protein complex. Additionally, a1-syntrophin interacts with SCN5A and nNOS-PMCA4b complex in cardiomyocytes. SNTA1 is a susceptibility locus for arrhythmia and cardiomyopathy. We generated a homozygous SNTA1 knockout human embryonic stem cell (H9SNTA1KO) using the CRISPR/Cas9 system. H9SNTA1KO maintained pluripotency and a normal karyotype and differentiated into three germ layers in vivo.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Generation of a MCPH1 knockout human embryonic stem cell line by CRISPR/Cas9 technology
    Wang, Zerui
    Cui, Yazhou
    Shan, Yongli
    Kang, Baoqiang
    Shi, Liang
    Geng, Kaiyue
    Han, Jinxiang
    [J]. STEM CELL RESEARCH, 2020, 49
  • [42] Generation of an ASGR1 homozygousmutant human embryonic stem cell line WAe001-A-6 using CRISPR/Cas9
    Xu, Yingying
    Wu, Yuhang
    Guo, Dongsheng
    Gao, Ge
    Lai, Keyu
    Yang, Fan
    Wang, Kepin
    Wu, Han
    Lai, Liangxue
    Li, Jialiang
    Xu, Kecheng
    Li, Yin-Xiong
    [J]. STEM CELL RESEARCH, 2017, 22 : 29 - 32
  • [43] Generation of two RNF2 homozygous knockout human embryonic stem cell lines by CRISPR/Cas9 system
    Shan, Yongli
    Ma, Lishi
    Zhang, Cong
    Zhang, Yanqi
    Zhang, Jingyuan
    Xiao, Lu
    Wei, Yanxing
    Yu, Yanhong
    [J]. STEM CELL RESEARCH, 2020, 47
  • [44] Establishment of a CRISPR/Cas9-mediated GATAD2B homozygous knockout human embryonic stem cell line
    Wang, Bo
    Zhu, Shuoji
    Deng, Yuzhi
    Sai, Xiyalatu
    Chen, Zerui
    Liu, Jian
    Li, Ge
    Liu, Nanbo
    Chen, Jimei
    Yu, Changjiang
    Sun, Tucheng
    Zhu, Ping
    [J]. STEM CELL RESEARCH, 2021, 57
  • [45] Generation of a COL1A2 homozygous knockout stem cell line via CRISPR/Cas9 system
    Ma, Shuhong
    Saleem, Amina
    Li, Xiaowei
    Lu, Wen-Jing
    Jiang, Hongfeng
    [J]. STEM CELL RESEARCH, 2022, 59
  • [46] Generation of a TBX20-knockout human embryonic stem line by CRISPR/Cas9 system
    Wu, Xiaodan
    Wang, Xiantao
    [J]. STEM CELL RESEARCH, 2023, 69
  • [47] Generation of an Abcc8 homozygous mutation human embryonic stem cell line using CRISPR/Cas9
    Guo, Dongsheng
    Liu, Haikun
    Gao, Ge
    Ruzi, Aynisahan
    Wang, Kepin
    Wu, Han
    Lai, Keyu
    Liu, Yanli
    Yang, Fan
    Lai, Liangxue
    Li, Yin-xiong
    [J]. STEM CELL RESEARCH, 2016, 17 (03) : 640 - 642
  • [48] Generation of a homozygous LRP2 knockout human embryonic stem cell line (FDCHDPe010-A-56) by CRISPR/Cas9 system
    You, Jie
    Cheng, Yun
    Yang, Xian-Jie
    Chen, Ling
    [J]. STEM CELL RESEARCH, 2021, 53
  • [49] Generation of a NONO homozygous knockout human induced pluripotent stem cell line by CRISPR/Cas9 editing
    Yi, Tong
    Bai, Rui
    Sun, Hairui
    Lan, Feng
    Zhang, Hongjia
    He, Yihua
    [J]. STEM CELL RESEARCH, 2020, 47
  • [50] Generation of CD16A gene knockout human embryonic stem cell line using CRISPR/Cas9
    Wu, Shunjie
    Deng, Haimei
    Lu, Bo
    Yuan, Lihua
    Wang, Xiaobo
    [J]. STEM CELL RESEARCH, 2022, 64